Loading chart…
PRE-MARKET
Nephrocare Health Services Limited provides dialysis healthcare services through a chain of kidney care clinics and dialysis centers in India, Uzbekistan, Nepal, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. The company was incorporated in 2009 and is based in Hyderabad, India.
Nephrocare Health Services Limited (NEPHROPLUS) is listed on the NSE in the Healthcare sector, Medical Care Facilities industry. The NEPHROPLUS share price is ₹601.75 (-1.34% today), with a market capitalisation of ₹61B and a price-to-earnings (P/E) ratio of 47.5. MarketRipple tracks the NEPHROPLUS investment thesis, the ripple-chain impact of market events on Nephrocare Health Services Limited, and the Healthcare sector outlook.
Open
₹606.40
High
₹609.25
Low
₹590.00
Prev. Close
₹609.95
52W High
₹781.50
52W Low
₹446.00
Day range
₹590.00–₹609.25
52-week range
₹446.00–₹781.50
Volume
107K
P/E
47.5
ROE
6.9%
D/E
0.07
Margin
8.1%
Nephrocare Health Services Limited (NSE: NEPHROPLUS) is currently trading at ₹601.75 (-1.34%).
Nephrocare Health Services Limited's market capitalization is ₹61B.
Nephrocare Health Services Limited's price-to-earnings (P/E) ratio is 47.5.
Nephrocare Health Services Limited operates in the Healthcare sector (Medical Care Facilities).
Analyst consensus on Nephrocare Health Services Limited currently reads neutral, based on 5 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.